Skip to main content
. 2021 Mar 3;10(2):103–110. doi: 10.4103/EUS-D-20-00073

Table 3.

Subjective response to neoadjuvant therapy

Patients (n=67), n (%)
Response
 Complete response 3 (4.5)
 Very good response 17 (25.4)
 Good response 14 (20.9)
 Response 11 (16.4)
Stable 21 (31.3)
Progression 1 (1.5)